By Jo CavalloNovember 25, 2019 William G. Kaelin, Jr, MD William G. Kaelin, Jr, MD, Sidney Farber Professor of Medicine and Howard Hughes Medical Institute Investigator at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, admits that early in his research career, he…
Official website for the University of Miami Leonard M. Miller School of Medicine
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show…
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show…
His two-decade quest to find elusive brain hormones became a race against Roger Guillemin, a onetime colleague and an eventual fellow prizewinner.
This summary includes information from the ARCHES and ENZAMET follow-up studies. Both studies looked at enzalutamide treatment for people with metastatic hormone-sensitive prostate cancer (known…
Shaun Stauffer, PhD, and Nima Sharifi, MD, discuss the roles of several proteins in castration resistant prostate cancer and their identification as novel targets for…
Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer…
In a retrospective cohort study reported in the Journal of Clinical Oncology, Habib and colleagues found that adjuvant chemotherapy benefited some groups of patients with…
As reported in the Journal of Clinical Oncology by Barata et al, final overall survival results of the phase II SWOG 1500 trial indicated no…
